TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,212,000 | – | 250,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nicholas Investment Partners, LP | 1,101,401 | $14,153,000 | 0.99% |
| Boxer Capital, LLC | 1,550,998 | $19,930,000 | 0.68% |
| ArrowMark Colorado Holdings LLC | 6,001,971 | $77,125,000 | 0.58% |
| Baker Brothers Advisors | 7,574,835 | $97,337,000 | 0.42% |
| SECTORAL ASSET MANAGEMENT INC | 405,094 | $5,205,000 | 0.40% |
| Redmile Group, LLC | 400,000 | $5,140,000 | 0.07% |
| Perceptive Advisors | 250,000 | $3,212,000 | 0.04% |
| FEDERATED HERMES, INC. | 1,030,000 | $13,236,000 | 0.03% |
| Alyeska Investment Group, L.P. | 50,000 | $643,000 | 0.01% |
| CAAS CAPITAL MANAGEMENT LP | 40,000 | $514,000 | 0.01% |